Carta a la directora
Necesidad de valorar el gasto farmacéutico y los resultados en salud obtenidos de manera conjunta
The need for joint evaluation of pharmaceutical expenditure and the health outcomes obtained
Javier Soto Álvarez
Departamento de Farmacoeconomía e Investigación de Resultados, Pfizer España, S.A., Madrid, España
Read
1840
Timeswas read the article
602
Total PDF
1238
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 6 | 6 | 12 |
| 2025 5 | 93 | 37 | 130 |
| 2025 4 | 79 | 33 | 112 |
| 2025 3 | 89 | 30 | 119 |
| 2025 2 | 83 | 26 | 109 |
| 2025 1 | 62 | 29 | 91 |
| 2024 12 | 48 | 23 | 71 |
| 2024 11 | 62 | 36 | 98 |
| 2024 10 | 58 | 35 | 93 |
| 2024 9 | 50 | 24 | 74 |
| 2024 8 | 53 | 29 | 82 |
| 2024 7 | 46 | 25 | 71 |
| 2024 6 | 40 | 17 | 57 |
| 2024 5 | 49 | 26 | 75 |
| 2024 4 | 34 | 30 | 64 |
| 2024 3 | 39 | 25 | 64 |
| 2024 2 | 35 | 38 | 73 |
| 2024 1 | 37 | 20 | 57 |
| 2023 12 | 23 | 8 | 31 |
| 2023 11 | 32 | 19 | 51 |
| 2023 10 | 32 | 15 | 47 |
| 2023 9 | 47 | 11 | 58 |
| 2023 8 | 35 | 13 | 48 |
| 2023 7 | 41 | 22 | 63 |
| 2023 6 | 43 | 12 | 55 |
| 2023 5 | 22 | 13 | 35 |
Show all
